“Analysis of the Association Between CFH Y402H Polymorphism and Response to Intravitreal Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (nAMD)”. 2018. Biomolecules and Biomedicine 18 (3): 260-67. https://doi.org/10.17305/bjbms.2018.2493.